Literature DB >> 12055183

Loss of androgen receptor transcriptional activity at the G(1)/S transition.

Elisabeth D Martinez1, Mark Danielsen.   

Abstract

Androgens are essential for the differentiation, growth, and maintenance of male-specific organs. The effects of androgens in cells are mediated by the androgen receptor (AR), a member of the nuclear receptor superfamily of transcription factors. Recently, transient transfection studies have shown that overexpression of cell cycle regulatory proteins affects the transcriptional activity of the AR. In this report, we characterize the transcriptional activity of endogenous AR through the cell cycle. We demonstrate that in G0, AR enhances transcription from an integrated steroid-responsive mouse mammary tumor virus promoter and also from an integrated androgen-specific probasin promoter. This activity is strongly reduced or abolished at the G(1)/S boundary. In S phase, the receptor regains activity, indicating that there is a transient regulatory event that inactivates the AR at the G(1)/S transition. This regulation is specific for the AR, since the related glucocorticoid receptor is transcriptionally active at the G(1)/S boundary. Not all of the effects of androgens are blocked, however, since androgens retain the ability to increase AR protein levels. The transcriptional inactivity of the AR at the G(1)/S junction coincides with a decrease in AR protein level, although activity can be partly rescued without an increase in receptor. Inhibition of histone deacetylases brings about this partial restoration of AR activity at the G(1)/S boundary, demonstrating the involvement of acetylation pathways in the cell cycle regulation of AR transcriptional activity. Finally, a model is proposed that explains the inactivity of the AR at the G(1)/S transition by integrating receptor levels, the action of cell cycle regulators, and the contribution of histone acetyltransferase-containing coactivators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055183     DOI: 10.1074/jbc.M112134200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Cyclins, cyclin dependent kinases, and regulation of steroid receptor action.

Authors:  N L Weigel; N L Moore
Journal:  Mol Cell Endocrinol       Date:  2007-01-05       Impact factor: 4.102

2.  Switching of chromatin-remodelling complexes for oestrogen receptor-alpha.

Authors:  Maiko Okada; Shin-ichiro Takezawa; Yoshihiro Mezaki; Ikuko Yamaoka; Ichiro Takada; Hirochika Kitagawa; Shigeaki Kato
Journal:  EMBO Rep       Date:  2008-05-02       Impact factor: 8.807

3.  Retinoblastoma protein plays multiple essential roles in the terminal differentiation of Sertoli cells.

Authors:  Roopa L Nalam; Claudia Andreu-Vieyra; Robert E Braun; Haruhiko Akiyama; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2009-10-09

4.  Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.

Authors:  Ramesh Narayanan; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.

Authors:  Susan Holbeck; Jianjun Chang; Anne M Best; Angie L Bookout; David J Mangelsdorf; Elisabeth D Martinez
Journal:  Mol Endocrinol       Date:  2010-04-07

6.  Investigation of testosterone-mediated non-transcriptional inhibition of Ca2+ in vascular smooth muscle cells.

Authors:  Zhongqian Hu; Rui Ma; Jianbin Gong
Journal:  Biomed Rep       Date:  2015-12-15

7.  Cell-cycle-dependent regulation of androgen receptor function.

Authors:  Yulia Koryakina; Karen E Knudsen; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2015-02-17       Impact factor: 5.678

8.  Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.

Authors:  Ramesh Narayanan; Abayomi A Adigun; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

9.  Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.

Authors:  Wenwei Lin; Jing Wu; Hanqing Dong; David Bouck; Fu-Yue Zeng; Taosheng Chen
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

10.  Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.

Authors:  Craig J Burd; Christin E Petre; Lisa M Morey; Ying Wang; Monica P Revelo; Christopher A Haiman; Shan Lu; Cecilia M Fenoglio-Preiser; Jiwen Li; Erik S Knudsen; Jiemin Wong; Karen E Knudsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.